Status:

TERMINATED

Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

Lead Sponsor:

Bausch Health Americas, Inc.

Conditions:

Hepatitis C, Chronic

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to examine the rapid virologic response (RVR) at combination therapy (CT) Week 4 between groups receiving a standard combination peginterferon alfa-2b/viramidine dosing re...

Detailed Description

This Phase 2b multicenter study, which is being conducted solely in the United States, consists of a randomized, double-blind, monotherapy period, where patients will receive either viramidine or plac...

Eligibility Criteria

Inclusion

  • Treatment-naive, genotype 1 only, compensated, chronic hepatitis C infected Caucasian or African-American patients
  • Body weight greater than 61 kg and not more than 87.3 kg
  • HCV RNA greater than 2 million copies/mL
  • Elevated measured or historical alanine aminotransferase
  • Hemoglobin at least 12.0 g/dL for females and at least 13.0 g/dL for males
  • Calculated creatinine clearance greater than 70 mL/min

Exclusion

  • Cirrhosis of the liver
  • Alanine aminotransferase greater than 3 times the upper limit of normal
  • Severe neuropsychiatric disorders
  • History or clinical manifestations of significant metabolic, hematological, pulmonary, ischemic, or unstable heart disease, gastrointestinal, neurological, renal, urological, endocrine, ophthalmologic disorders including severe retinopathy, or immune mediated disease
  • Other co-morbid chronic viral infections including hepatitis B and the human immunodeficiency virus (HIV)

Key Trial Info

Start Date :

November 1 2005

Trial Type :

INTERVENTIONAL

End Date :

May 1 2007

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00305383

Start Date

November 1 2005

End Date

May 1 2007

Last Update

June 22 2012

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

University of Southern California -- Keck School of Medicine

Los Angeles, California, United States, 90033

2

San Mateo Medical Center

San Mateo, California, United States, 94403

3

Bach and Godofsky

Bradenton, Florida, United States, 34205

4

University of Miami -- Center for Liver Diseases

Miami, Florida, United States, 33136